MedDataX Logo

Application of Machine Learning Algorithms to Identify Optimal Candidates for Primary Tumor Resection in Patients with Metastatic Non-small Cell Neuroendocrine Tumors

NCT ID: NCT06621147

Last Updated: 2024-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1776 participants

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was based on public use data from the SEER database. The study did not require informed consent from the SEER registered cases, and the authors obtained Limited-Use Data Agreements from SEER.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

NCT06255197

Lung Cancer Lung Adenocarcinoma Lung Squamous Cell Carcinoma +2 more
RECRUITING

Postoperative Pulmonary Function Assessment Based on Deep Learning Study

NCT07256457

Lung Cancer (NSCLC)
NOT_YET_RECRUITING NA

Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection

NCT06659601

Focus on Developing a Deep Learning Model to Predict the Recurrence Risk of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection
COMPLETED

Imaging-based Deep Learning for Lung Cancer Diagnosis and Staging

NCT04000620

Lung Cancer
UNKNOWN

Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning Model

NCT06771947

Lung Cancer
NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study utilized publicly available data from the SEER (Surveillance, Epidemiology, and End Results) database, which is a comprehensive source of information on cancer statistics in the United States. The authors did not need to obtain informed consent from individuals whose cases are registered in the SEER database because the data is anonymized and is meant for public use. Instead, the authors acquired Limited-Use Data Agreements with SEER, which are legal contracts that allow researchers to access and use specific datasets under certain conditions while ensuring that the privacy of the individuals in the database is maintained. This agreement outlines the terms of data use, ensuring that the researchers adhere to guidelines for the ethical handling of data while still enabling them to conduct their research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer - Non Small Cell

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery

Surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pathologic Diagnosis of Non-Small Cell Neuroendocrine Carcinoma
* Known Surgical Information

Exclusion Criteria

* Small cell lung cancer
* Age less than 18 years
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital of Nanchang University

OTHER

Sponsor Role collaborator

Hongquan Xing

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hongquan Xing

Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NanchangU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer
NCT03066297 ACTIVE_NOT_RECRUITING
Prognostic Significance of the Uncertain Resection in NSCLC
NCT06511661 ACTIVE_NOT_RECRUITING
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916 RECRUITING
Establishment of a Feasibility Model for NOSE Surgery Based on Machine Learning
NCT05797064 NOT_YET_RECRUITING
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy
NCT06285058 NOT_YET_RECRUITING
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
NCT06653478 RECRUITING
Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery
NCT06016881 UNKNOWN
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418 RECRUITING
HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections
NCT05676788 NOT_YET_RECRUITING NA
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904 NOT_YET_RECRUITING
Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer
NCT07107035 NOT_YET_RECRUITING
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
NCT06483698 RECRUITING
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489 RECRUITING
Perioperative Treatment Outcomes of Early NSCLC
NCT06610240 ENROLLING_BY_INVITATION
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy
NCT05584267 RECRUITING PHASE2
Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm
NCT06634979 RECRUITING NA
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 COMPLETED
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
NCT05732974 RECRUITING
A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
NCT07119190 NOT_YET_RECRUITING
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 UNKNOWN
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer
NCT06405815 COMPLETED
Integrating Machine Learning for Prognostic Prediction in Stage I NSCLC by CT Images and Pathological Factors
NCT06737367 COMPLETED
Machine Learning for Predicting and Managing Quality of Life in Lung Cancer Immunotherapy Patients
NCT06725225 NOT_YET_RECRUITING NA
Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
NCT06644066 RECRUITING NA
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
NCT03357094 UNKNOWN